| A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus (NCT07482657) | Enanta Pharmaceuticals, Inc | 2026-07-09 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults (NCT07540910) | Enanta Pharmaceuticals, Inc | 2026-04-01 |
| A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323. (NCT06847464) | Enanta Pharmaceuticals, Inc | 2025-01-27 |
| A Study to Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy Adults (NCT06601192) | Enanta Pharmaceuticals, Inc | 2024-07-15 |
| A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge Model (NCT06170242) | Enanta Pharmaceuticals, Inc | 2023-11-20 |
| A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications. (NCT05568706) | Enanta Pharmaceuticals, Inc | 2022-11-29 |
| A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19 (NCT05616728) | Enanta Pharmaceuticals, Inc | 2022-11-10 |
| Drug-Drug Interaction Study Between EDP-235, Itraconazole, Carbamazepine and Quinidine in Healthy Subjects. (NCT05594602) | Enanta Pharmaceuticals, Inc | 2022-10-06 |
| Drug-Drug Interaction Study Between EDP-235, Midazolam, Caffeine and Rosuvastatin in Healthy Subjects (NCT05594615) | Enanta Pharmaceuticals, Inc | 2022-10-06 |
| A Study of EDP-323 in Healthy Subjects (NCT05587478) | Enanta Pharmaceuticals, Inc | 2022-09-29 |
| A Study of EDP-235 in Healthy Subjects (NCT05246878) | Enanta Pharmaceuticals, Inc | 2022-01-28 |
| Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory Tract (NCT04633187) | Enanta Pharmaceuticals, Inc | 2021-07-07 |
| Absorption, Metabolism, and Excretion (AME) Study of [14C]EDP-938 in Healthy Male Subjects (NCT04927793) | Enanta Pharmaceuticals, Inc | 2021-05-28 |
| Drug-Drug Interaction Study Between Fluconazole and EDP-938 in Healthy Subjects (NCT04871724) | Enanta Pharmaceuticals, Inc | 2021-03-12 |
| Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy Subjects (NCT04783753) | Enanta Pharmaceuticals, Inc | 2020-11-05 |
| A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment (NCT04470388) | Enanta Pharmaceuticals, Inc | 2020-09-09 |
| A Study of EDP-297 in Healthy Subjects (NCT04559126) | Enanta Pharmaceuticals, Inc | 2020-09-08 |
| A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH (NCT04378010) | Enanta Pharmaceuticals, Inc | 2020-01-27 |
| A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult Subjects (NCT04196101) | Enanta Pharmaceuticals, Inc | 2020-01-22 |
| A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2) (NCT04008004) | Enanta Pharmaceuticals, Inc | 2019-06-26 |
| Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects (NCT03755778) | Enanta Pharmaceuticals, Inc | 2018-11-29 |
| A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects (NCT03783897) | Enanta Pharmaceuticals, Inc | 2018-11-27 |
| Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult Subjects (NCT03750383) | Enanta Pharmaceuticals, Inc | 2018-11-02 |
| A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model (NCT03691623) | Enanta Pharmaceuticals, Inc | 2018-10-15 |
| Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects (NCT03748628) | Enanta Pharmaceuticals, Inc | 2018-10-05 |
| Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers (NCT03610945) | Enanta Pharmaceuticals, Inc | 2018-07-19 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NCT03421431) | Enanta Pharmaceuticals, Inc | 2018-04-25 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (NCT03394924) | Enanta Pharmaceuticals, Inc | 2017-12-27 |
| A Study of EDP-938 in Healthy Subjects (NCT03384823) | Enanta Pharmaceuticals, Inc | 2017-12-07 |